Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has announcements
×
Recurrence
×
ibrutinib
×
Clear all
Filters
3
NCT03734016
2025-03-30
ALPINE
BeiGene
Phase 3
Completed
652 enrolled
27 charts
1 FDA